Week Ending October 24, 2022

Among People with Hemophilia, HCV Prevention is Working, But Eradication Remains Elusive
“A new review article suggests it is possible to eradicate hepatitis C virus infections among people with hemophilia, but it will take intense focus from public health agencies.”

Partnering With Patients Is Cornerstone, Says New ASCO President
“Eric Winer, MD, the current president of the American Society of Clinical Oncology (ASCO), talks with great fondness about former patients, many of whom have given him mementos that hang in his office.”

Primary Care Evaluation of a Hepatitis C Virus (HCV) Screening Education Intervention
“Increased screening efforts and the development of effective antiviral treatments have led to marked improvement in Hepatitis C (HCV) patient outcomes. However, many people in the US are believed to have undiagnosed HCV. Successful screening strategies and access to a coordinated system of care are critical for HCV affected adults.”

Liver Cancer Risk Falls After Hepatitis C Treatment
“The risk of liver cancer is reduced after successful antiviral therapy for hepatitis C, according to study results published in Gastroenterology. But even after seven years, the risk remains high enough to warrant continued screening for hepatocellular carcinoma in certain groups.”

HIV, Hepatitis C Coinfection Increases Cardiovascular Risk
“The risk of myocardial infarction increases among individuals with hepatitis C virus (HCV) and HIV as they age, according to a recent study.”